SEARCH:   Advanced

Blood, 1 December 2004, Vol. 104, No. 12, pp. 3746-3753. Prepublished online as a Blood First Edition Paper on August 10, 2004; DOI 10.1182/blood-2004-05-1941. This Article Full Text Full Text (PDF) All Versions of this Article: 2004-05-1941v1 104/12/3746    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Nowicki, M. O. Articles by Skorski, T. Search for Related Content PubMed PubMed Citation Articles by Nowicki, M. O. Articles by Skorski, T. Related Collections Oncogenes and Tumor Suppressors Neoplasia Related Article in Blood Online Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  NEOPLASIA BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species–dependent DNA double-strand breaks Michal O. Nowicki, Rafal Falinski, Mateusz Koptyra, Artur Slupianek, Tomasz Stoklosa, Ewa Gloc, Margaret Nieborowska-Skorska, Janusz Blasiak, and Tomasz Skorski From the Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA; and the Department of Molecular Genetics, University of Lodz, Poland. The oncogenic BCR/ABL tyrosine kinase induces constitutive DNA damage in Philadelphia chromosome (Ph)-positive leukemia cells. We find that BCR/ABL-induced reactive oxygen species (ROSs) cause chronic oxidative DNA damage resulting in double-strand breaks (DSBs) in S and G2/M cell cycle phases. These lesions are repaired by BCR/ABL-stimulated homologous recombination repair (HRR) and nonhomologous end-joining (NHEJ) mechanisms. A high mutation rate is detected in HRR products in BCR/ABL-positive cells, but not in the normal counterparts. In addition, large deletions are found in NHEJ products exclusively in BCR/ABL cells. We propose that the following series of events may contribute to genomic instability of Ph-positive leukemias: BCR/ABL ROSs oxidative DNA damage DSBs in proliferating cells unfaithful HRR and NHEJ repair. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? Related Article in Blood Online: Genetic rearrangements beget genomic instability Feyruz V. Rassool Blood 2004 104: 3424-3425. [Full Text] [PDF] This article has been cited by other articles: A. Sallmyr, A. E. Tomkinson, and F. V. Rassool Up-regulation of WRN and DNA ligase III{alpha} in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks Blood, August 15, 2008; 112(4): 1413 - 1423. [Abstract] [Full Text] [PDF] T. Stoklosa, T. Poplawski, M. Koptyra, M. Nieborowska-Skorska, G. Basak, A. Slupianek, M. Rayevskaya, I. Seferynska, L. Herrera, J. Blasiak, et al. BCR/ABL Inhibits Mismatch Repair to Protect from Apoptosis and Induce Point Mutations Cancer Res., April 15, 2008; 68(8): 2576 - 2580. [Abstract] [Full Text] [PDF] F. V. Rassool, T. J. Gaymes, N. Omidvar, N. Brady, S. Beurlet, M. Pla, M. Reboul, N. Lea, C. Chomienne, N. S.B. Thomas, et al. Reactive Oxygen Species, DNA Damage, and Error-Prone Repair: A Model for Genomic Instability with Progression in Myeloid Leukemia? Cancer Res., September 15, 2007; 67(18): 8762 - 8771. [Abstract] [Full Text] [PDF] L. Rink, A. Slupianek, T. Stoklosa, M. Nieborowska-Skorska, K. Urbanska, I. Seferynska, K. Reiss, and T. Skorski Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells Blood, July 15, 2007; 110(2): 651 - 660. [Abstract] [Full Text] [PDF] M. S. Rodrigues and M. Sattler Chronic Myelogenous Leukemia Progenitors Display a Genetically Unstable Personality J Natl Cancer Inst, May 2, 2007; 99(9): 662 - 663. [Full Text] [PDF] F. Michor Chronic Myeloid Leukemia Blast Crisis Arises from Progenitors Stem Cells, May 1, 2007; 25(5): 1114 - 1118. [Abstract] [Full Text] [PDF] C. Yoshida, F. Yoshida, D. E. Sears, S. M. Hart, D. Ikebe, A. Muto, S. Basu, K. Igarashi, and J. V. Melo Bcr-Abl signaling through the PI-3/S6 kinase pathway inhibits nuclear translocation of the transcription factor Bach2, which represses the antiapoptotic factor heme oxygenase-1 Blood, February 1, 2007; 109(3): 1211 - 1219. [Abstract] [Full Text] [PDF] K. Wolanin, A. Magalska, G. Mosieniak, R. Klinger, S. McKenna, S. Vejda, E. Sikora, and K. Piwocka Curcumin Affects Components of the Chromosomal Passenger Complex and Induces Mitotic Catastrophe in Apoptosis-Resistant Bcr-Abl-Expressing Cells Mol. Cancer Res., July 1, 2006; 4(7): 457 - 469. [Abstract] [Full Text] [PDF] M. Koptyra, R. Falinski, M. O. Nowicki, T. Stoklosa, I. Majsterek, M. Nieborowska-Skorska, J. Blasiak, and T. Skorski BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance Blood, July 1, 2006; 108(1): 319 - 327. [Abstract] [Full Text] [PDF] H. G. Jorgensen, M. Copland, E. K. Allan, X. Jiang, A. Eaves, C. Eaves, and T. L. Holyoake Intermittent Exposure of Primitive Quiescent Chronic Myeloid Leukemia Cells to Granulocyte-Colony Stimulating Factor In vitro Promotes their Elimination by Imatinib Mesylate Clin. Cancer Res., January 15, 2006; 12(2): 626 - 633. [Abstract] [Full Text] [PDF] S. M. Wiesner, J. M. Jones, D. E. Hasz, and D. A. Largaespada Repressible transgenic model of NRAS oncogene-driven mast cell disease in the mouse Blood, August 1, 2005; 106(3): 1054 - 1062. [Abstract] [Full Text] [PDF] N. L. Komarova and D. Wodarz Drug resistance in cancer: Principles of emergence and prevention PNAS, July 5, 2005; 102(27): 9714 - 9719. [Abstract] [Full Text] [PDF]

	Blood Online is supported in part by Genentech BioOncology and Biogen Idec
	Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020